Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

Ravani, P; Ponticelli, A; Siciliano, C; Fornoni, A; Magnasco, A; Sica, F; Bodria, M; Caridi, G; Wei, C; Belingheri, M; Ghio, L; Merscher Gomez, S; Edefonti, A; Pasini, A; Montini, G; Murtas, C; Wang, X; Muruve, D; Vaglio, A; Martorana, D; Pani, A; Scolari, Francesco; Reiser, J; Ghiggeri, G. M.